Edwards Lifesciences Corp. (EW) reported third quarter EPS of $0.71 after the close Wednesday, which beat the consensus estimate of $0.70. The company expects to report fourth quarter EPS of $0.82 to $0.86 and full year EPS of $3.02 to $3.06. The consensus estimates are for EPS of $0.83 and $3.03 respectively.
Edwards Lifesciences gapped up slightly Thursday and rose steadily throughout the first 2 hours of trade. Shares traded in a range for the rest of the day and closed higher by $4.94 at $76.04 on the highest volume in 5 months. The stock has been on an upward trend since the beginning of September and set a new high for the year.
For comments and feedback: editorial@rttnews.com